Nagareyama, Japan

Takashi Tsuji

This inventor holds 52 USPTO granted patents and 18 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in Semiconductor Technology. Top assignees: Fuji Electric Co., Ltd., Organ Technologies, Inc., Sanford Burnham Prebys Medical Discovery Institute. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Tsuji. Retrieved from https://idiyas.com/inventor/takashi-tsuji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52 

% Patents Active = 65.4

 

 

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 150(Granted Patents)

Forward Citations (Not Self Cited) = 138(Dec 10, 2025)


Location History:

  • Nagareyama, JP (2004 - 2018)
  • Chiba, JP (2011 - 2018)
  • Tsukuba, JP (2016 - 2018)
  • Nagano, JP (2008 - 2019)
  • Kyoto, JP (2019)
  • Matsumoto, JP (2009 - 2021)
  • Wako, JP (2021)
  • Tokyo, JP (2010 - 2024)

Company Filing History:


Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Silicon Carbide
Semiconductor Device
Hair Growth Agent
Regenerative Organ
Tooth Production
Health Measurement
Fused Ring Compound
Azole Derivative
Glycosylated Peptide
Biaryl Derivative
Hair Follicle
Perfusion Culture
52 patents (USPTO):Explore Patents

Title: The Innovations of Takashi Tsuji

Introduction

Takashi Tsuji is a noteworthy inventor based in Nagareyama, Japan, distinguished by his extensive contribution to the field of pharmaceuticals. With an impressive portfolio of 45 patents, Tsuji has played a pivotal role in developing innovative compounds aimed at treating various medical conditions. His work not only reflects his scientific prowess but also highlights the potential of his inventions to impact healthcare positively.

Latest Patents

Among his latest patents, Tsuji has developed novel azole derivatives that act as apelin receptor agonists. This advancement is particularly significant, as it provides a method for treating cardiovascular diseases, diabetes, renal diseases, hypertension, and arteriosclerosis. The invention details a compound represented by a specific formula, crucial for developing therapeutic applications.

Another notable patent involves a biaryl derivative, which consists of a compound or its pharmacologically acceptable salt that exhibits excellent tissue non-specific alkaline phosphatase inhibitory activity. This patented compound is described by a formula that includes a variety of functional groups, all contributing to its therapeutic relevance.

Career Highlights

Takashi Tsuji's career includes positions at prestigious companies such as Fuji Electric Co., Ltd. and Organ Technologies, Inc. His dedication to research and development at these institutions has been instrumental in bringing innovative solutions to the market, particularly in the pharmaceutical sector.

Collaborations

Throughout his career, Tsuji has collaborated with esteemed colleagues, including Akimasa Kinoshita and Kenji Fukuda. These partnerships have fostered an environment of innovation and have contributed to the success of his research endeavors.

Conclusion

In conclusion, Takashi Tsuji's contributions to pharmaceutical innovations through his extensive patent portfolio are noteworthy. His inventions not only advance scientific understanding but also hold the potential to significantly improve patient care across various health conditions. As he continues to push the boundaries of research, Tsuji remains a prominent figure in the field of drug development and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…